Is APRE up or down today?
APRE is down 1.94% today, last at 0.7739. This stock moved -1.94% versus the prior close.
APRE · APRE
APRE (APRE) is trading at 0.7739, down 1.94% on the session. APRE carries a 14-day RSI of 51, and trades above its 50-day average. Over the past month it is up 13.31%.
Leading the coverage: “Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs” (Yahoo, 15d ago). APRE is -6.28% since story.
APRE trades on a trailing P/E of 34.3 and is running 14.37% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
APRE is down 1.94% today, last at 0.7739. This stock moved -1.94% versus the prior close.
Leading the coverage: “Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs” (Yahoo, 15d ago). APRE is -6.28% since story. Dominant story: Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference (1 source, neutral) RSI is 51 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
Aprea Therapeutics Expands Current Patent Portfolio
Aprea Therapeutics records second consecutive surge, jumping another 22% (APRE:NASDAQ) - Seeking Alpha
Aprea (APRE) Q1 2026 Earnings: EPS Prints Above Forecast in the Latest Session; Trading Move: The Stock Gains 1.19% in the Current Update - Earnings Expansion Phase - vinanet.vn